Cite
HARVARD Citation
Miller, T. et al. (n.d.). P3‐055: SYSTEMS BIOLOGY PLATFORM TO ENABLE NEUROINFLAMMATORY TARGET ID, VALIDATION, AND PATIENT SELECTION FOR DISEASE‐MODIFYING ALZHEIMER'S DISEASE THERAPEUTICS. Alzheimer's & dementia. p. P947. [Online].